These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4464228)

  • 1. [Early results of treatment of patients with chronic pulmonary tuberculosis with rifampicin].
    Böszörmenyi M
    Gruzlica; 1974 May; 42(5):407-10. PubMed ID: 4464228
    [No Abstract]   [Full Text] [Related]  

  • 2. [Long-term results of treatment with rifampicin and ethambutol in hyperchronic pulmonary tuberculosis with polyresistant bacilli].
    Anastasatu C; Sibila S
    Ftiziologia; 1973; 22(5):477-84. PubMed ID: 4751363
    [No Abstract]   [Full Text] [Related]  

  • 3. [Side effects of rifampicin in the treatment of chronic pulmonary tuberculosis by the intermittent method].
    Kost A
    Pol Tyg Lek; 1975 Mar; 30(13):557-8. PubMed ID: 1121469
    [No Abstract]   [Full Text] [Related]  

  • 4. [Late results of treatment of chronic pulmonary tuberculosis with rifampicin].
    Lachowicz E; Polaczek E; Araszkiewicz W; Kozakow H; Pszonicka A; Styszewska H; Janowiec M; Grabowska R
    Gruzlica; 1973 Jul; 41(7):781-7. PubMed ID: 4730979
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of chronic pulmonary tuberculosis with rifampin and ethambutol by the continuous and intermittent methods].
    Kotowska M; Zelski S
    Gruzlica; 1974 May; 42(5):417-9. PubMed ID: 4464230
    [No Abstract]   [Full Text] [Related]  

  • 6. [Late results of 12-month-long hospital treatment of chronic pulmonary tuberculosis with rifampicin combined with other antitubercular agents].
    Danilczuk R; Piekarniak K; Wyczólkowski M; Martyniak K
    Pneumonol Pol; 1977 Feb; 45(2):125-30. PubMed ID: 840724
    [No Abstract]   [Full Text] [Related]  

  • 7. Rifampicin in the treatment of resistant pulmonary tuberculosis.
    Wäre M; Lorenzen J
    Scand J Respir Dis Suppl; 1970; 72():113-9. PubMed ID: 4990617
    [No Abstract]   [Full Text] [Related]  

  • 8. [Rifampicin and ethanbutol in daily and intermittent treatment of chronic advanced cavernous pulmonary tuberculosis resistant to many drugs. Preliminary communication. Early results].
    Zierski M; Bek E; Kucharska A; Graczyk J; Bukalska Z
    Gruzlica; 1973 Nov; 41(11):1129-37. PubMed ID: 4765793
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experience with the use of rifampicin (rimactan) in patients with chronic destructive forms of pulmonary tuberculosis].
    Ginzburg ZI
    Probl Tuberk; 1971; 49(12):77-8. PubMed ID: 5145746
    [No Abstract]   [Full Text] [Related]  

  • 10. [ rpceedomgs" Intermittent 2-phase regimen in therapy of chronic pulmonary tuberculosis].
    Zierski M
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):116-23. PubMed ID: 4491708
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical effects of rifampicin applied every other day for severe cavitary pulmonary tuberculosis].
    Hashimoto T; Takahashi S; Kasai K; Tamura M; Yamada M
    Kekkaku; 1972 Aug; 47(8):273-7. PubMed ID: 4660855
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical and radiological results of rifampicin therapy in chronic pulmonary tuberculosis].
    Merenda P
    G Ital Mal Torace; 1969; ():Suppl 2:105-6. PubMed ID: 5357132
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of treatment of chronically infectious patients with rifampicin in various combinations and in various models].
    Górecki R; Stanek S
    Gruzlica; 1974 May; 42(5):411-6. PubMed ID: 4464229
    [No Abstract]   [Full Text] [Related]  

  • 14. [Proceedings: Preliminary results of a 2-phase therapy with rifampicin, ethambutol and a third drug in chronic polyresistant tuberculoses].
    Neumeyer D; Anschel R; Eule H; Fichtner K; Ganguin HG; Pickroth G
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):135-8. PubMed ID: 4491710
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intermittent treatment of "intractable chronic tuberculosis" by combined rifampicin-ethambutol: preliminary results of a controlled survey made in Algeria].
    Larbaoui D; Chaulet P; Grosset J; Abderrahim K; Oussedik N; Coucke C; Benabdallah L
    Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):559-66. PubMed ID: 4928583
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the effectiveness of rifampicin and ethambutol used in 3 different therapeutical schemes in drug-resistant chronic pulmonary tuberculosis].
    Andrian A; Ciobanu V; Cojocaru G; Borşaru I; Ciobanu D; Spirescu G; Roşianu D; Pescariu M
    Ftiziologia; 1971; 20(6):623-8. PubMed ID: 5162289
    [No Abstract]   [Full Text] [Related]  

  • 17. [1st observations on the activity of the oral Rifampicin in the treatment of chronic pulmonary tuberculosis].
    Daddi G; Cornia G; Grassi C; Perna G; Scarpazza G
    G Ital Mal Torace; 1967; 21(3):131-6. PubMed ID: 5604472
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical use of rifampicin (R-AMP) in chronic pulmonary tuberculosis].
    Casalone G; Giura R; Lusco G
    G Ital Mal Torace; 1968; 22(4):215-8. PubMed ID: 5743003
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rifampicin and ethambutol treatment experience in chronic destructive pulmonary tuberculosis].
    Petrova GN; Sedunova EA; Korotaeva TA
    Probl Tuberk; 1981 Mar; (3):73-4. PubMed ID: 7232397
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of pulmonary tuberculosis of native Black Africans a chemotherapeutic regime including rifampicin (apropos of 75 patients)].
    Ayad M; Hane A; Kane PA
    Dakar Med; 1980; 25(1):65-74. PubMed ID: 7460740
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.